tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GB:FARN Stock Latest News

Faron plans €40m rights issue to fund bexmarilimab through key cancer trial milestones
Company AnnouncementsFaron plans €40m rights issue to fund bexmarilimab through key cancer trial milestones
7d ago
Faron Registers 909,517 New Shares After Exercise of Special Rights
PremiumCompany Announcements
Faron Registers 909,517 New Shares After Exercise of Special Rights
13d ago
Faron Uses Share Settlement to Amortise Convertible Bonds, Adding 909,517 New Shares
PremiumCompany Announcements
Faron Uses Share Settlement to Amortise Convertible Bonds, Adding 909,517 New Shares
13d ago
Faron CFO Sells Entire Personal Stake in Biopharma Group
PremiumCompany Announcements
Faron CFO Sells Entire Personal Stake in Biopharma Group
1M ago
Faron Uses Treasury Shares to Settle Advanced Bond Amortisation and Adjusts Maturity Profile
PremiumCompany Announcements
Faron Uses Treasury Shares to Settle Advanced Bond Amortisation and Adjusts Maturity Profile
1M ago
Faron Pharmaceuticals Revises Shareholders’ Nomination Board Composition
PremiumCompany AnnouncementsFaron Pharmaceuticals Revises Shareholders’ Nomination Board Composition
2M ago
Promising Potential of Faron Pharmaceuticals’ Bexmarilimab in Treating High-Risk Myelodysplastic Syndromes and Solid Tumors Justifies Buy Rating
Premium
Ratings
Promising Potential of Faron Pharmaceuticals’ Bexmarilimab in Treating High-Risk Myelodysplastic Syndromes and Solid Tumors Justifies Buy Rating
2M ago
Faron Pharmaceuticals Strengthens Financial Position with EUR 10 Million Bond Issuance
Premium
Company Announcements
Faron Pharmaceuticals Strengthens Financial Position with EUR 10 Million Bond Issuance
2M ago
Promising Clinical Trial Results and Strategic Advancements Justify Buy Rating for Faron Pharmaceuticals
PremiumRatings
Promising Clinical Trial Results and Strategic Advancements Justify Buy Rating for Faron Pharmaceuticals
2M ago
Faron Pharmaceuticals Registers New Shares Following Special Rights Exercise
PremiumCompany Announcements
Faron Pharmaceuticals Registers New Shares Following Special Rights Exercise
3M ago
Faron Pharmaceuticals Approves New Share Issuance to Manage Convertible Bonds
PremiumCompany Announcements
Faron Pharmaceuticals Approves New Share Issuance to Manage Convertible Bonds
3M ago
Faron Pharmaceuticals Grants 180,000 Share Options
PremiumCompany Announcements
Faron Pharmaceuticals Grants 180,000 Share Options
3M ago
Faron Pharmaceuticals Announces Grant of 180,000 Share Options
PremiumCompany AnnouncementsFaron Pharmaceuticals Announces Grant of 180,000 Share Options
3M ago
Faron Pharmaceuticals Appoints New CFO to Drive Growth
Premium
Company Announcements
Faron Pharmaceuticals Appoints New CFO to Drive Growth
3M ago
Faron Pharmaceuticals Announces 2026 Financial Reporting Schedule
Premium
Company Announcements
Faron Pharmaceuticals Announces 2026 Financial Reporting Schedule
3M ago
Faron Pharmaceuticals to Issue Second Tranche of Convertible Bonds Worth EUR 10 Million
PremiumCompany Announcements
Faron Pharmaceuticals to Issue Second Tranche of Convertible Bonds Worth EUR 10 Million
3M ago
Faron Pharmaceuticals Oy: Promising BEXMAB Phase 2 Trial Results and FDA Endorsement Support Buy Rating
PremiumRatings
Faron Pharmaceuticals Oy: Promising BEXMAB Phase 2 Trial Results and FDA Endorsement Support Buy Rating
3M ago
Faron Pharmaceuticals Approves Share Subscriptions Amid Bond Amortisation
PremiumCompany Announcements
Faron Pharmaceuticals Approves Share Subscriptions Amid Bond Amortisation
4M ago
Faron Pharmaceuticals’ Bexmarilimab Shows Promising Results in High-Risk Myelodysplastic Syndrome, Supporting Buy Rating
PremiumRatings
Faron Pharmaceuticals’ Bexmarilimab Shows Promising Results in High-Risk Myelodysplastic Syndrome, Supporting Buy Rating
4M ago
Faron Pharmaceuticals’ Bexmarilimab Shows Promising Results in HR-MDS Treatment
PremiumCompany AnnouncementsFaron Pharmaceuticals’ Bexmarilimab Shows Promising Results in HR-MDS Treatment
4M ago
Faron Pharmaceuticals Registers New Shares to Enhance Market Position
Premium
Company Announcements
Faron Pharmaceuticals Registers New Shares to Enhance Market Position
5M ago
Faron Pharmaceuticals Approves New Share Issuance Amid Convertible Bond Strategy
Premium
Company Announcements
Faron Pharmaceuticals Approves New Share Issuance Amid Convertible Bond Strategy
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >